Registry of Lobbyists

Registration - Consultant

Sanofi Canada / Sanofi Canada / CARL BALTARE, Consultant

Registration Information

Client name: Sanofi Canada / Sanofi Canada
Previous client names
Lobbyist name: CARL BALTARE, Consultant
Initial registration start date: 2005-04-26
Registration status: Inactive
Registration Number: 776307-3842

Associated Communications

Total Number of Communication Reports: 5

Monthly communication reports in the last 6 months: 0

Version 4 of 12 (2006-10-17 to 2007-05-07)

Version 4 of 12 (2006-10-17 to 2007-05-07) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: CARL BALTARE    Lobbyist business address
Consulting firm: GLOBAL PUBLIC AFFAIRS
50 O'CONNOR ST.
SUITE 901
OTTAWA, ON  K1P 6L2
Canada
Position: CHAIRMAN
Telephone number: 613-783-3455  
Fax number: 613-782-2426  
 
Former public office holder: Yes
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: SANOFI AVENTIS CANADA
2150 ST ELZEAR BLVD
LAVAL, QC  H7L 4A8
Canada
Telephone number: 514-956-4098
 
Client Representative: MICHEL TREMBLAY
 
The client is a subsidiary of the following parent companies: SANOFI AVENTIS
174 AVE. DE FRANCE
PARIS 75013
France

Coalition: The client is not a coalition.
The client has the following subsidiaries which have a direct interest in the lobbying activities: AVENTIS PHARMA GERMANY GMBH
BUILDING F821 INDUSTRIAL ESTATE
HOESCHT 65926
Germany

DERMIK LABORATORIES INC
1050 WESTLAKES DRIVE
BERWYN, PA
United States of America 19312

MERIAL LIMITED
SANDRINGHAM HOUSE HARLOW BUSINESS PARK
ESSEX CM195TG
United Kingdom

SANOFI PASTEUR INC
DISCOVERY DRIVE
SWIFTWATER, PA
United States of America 18370

SANOFI PASTEUR MSD LTD
MALLARDS REACH BRIDGE AVENUE
MAIDENHEAD SL61QP
United Kingdom

Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Consumer Issues, Health, Industry, Intellectual Property, International Trade, Science and Technology
 

Details Regarding the Identified Subject Matter

Categories Description
Policy or Program ENSURE UNDERSTANDING AND INPUT REGARDING HEALTH AND PHARMACEUTICALS RESEARCH, DEVELOPMENT, INTELLECTUAL PROPERTY, STRATEGIC POLICY, NATIONAL PHARMACEUTICALS STRATEGY AND INTERNET PHARMACIES; DRUG APPROVALS; RESEARCH & DEVELOPMENT; INTELLECTUAL PROPERTY; CANADIAN AGENCY FOR DRUGS & TECHNOLOGIES IN HEALTH; COMMON DRUG REVIEW; PATENTED MEDICINES PRICES REVIEW BOARD
Regulation FOOD AND DRUGS ACT AND REGULATIONS, PATENT ACT REGULATIONS




Date Modified: